Glycosylation modulation as a therapeutic strategy for neuroinflammatory disorders: The potential of Tanshinone IIA
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China (2022YFC3500501)
- National Natural Science Foundation of China (82474103)
- National Natural Science Foundation of China (82174004)
- National Natural Science Foundation of China (82471479)
This publication has 66 references indexed in Scilit:
- Uridine depletion impairs CD8⁺ T cell antitumor activity through N-glycosylationCell Metabolism, 2025
- Understanding glycosylation: Regulation through the metabolic flux of precursor pathwaysBiotechnology Advances, 2023
- The Dialogue Between Neuroinflammation and Adult Neurogenesis: Mechanisms Involved and Alterations in Neurological DiseasesMolecular Neurobiology, 2022
- Terpolymeric platform with enhanced hydrophilicity via cysteic acid for serum intact glycopeptide analysisMicrochimica Acta, 2022
- Brain glycogen serves as a critical glucosamine cache required for protein glycosylationCell Metabolism, 2021
- Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's diseaseClinical Biochemistry, 2019
- Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injuryBrain, Behavior, and Immunity, 2017
- Irgm1 promotes M1 but not M2 macrophage polarization in atherosclerosis pathogenesis and developmentAtherosclerosis, 2016
- Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationGlia, 2007
- Correction: LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantationCell, 1993